Palmitelaidic Acid
| Code | Size | Price |
|---|
| TAR-T19500-10mg | 10mg | £135.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Palmitelaidic Acid is one of the most abundant fatty acids in serum and tissue.
CAS:
10030-73-6
Formula:
C16H30O2
Molecular Weight:
254.414
Pathway:
Metabolism; Chromatin/Epigenetic; PI3K/Akt/mTOR signaling; DNA Damage/DNA Repair
Purity:
0.98
SMILES:
CCCCCCC=CCCCCCCCC(O)=O
Target:
Glucokinase; AMPK; PPAR
References
1. Yang ZH, et al. Chronic administration of palmitoleic acid reduces insulin resistance and hepatic lipid accumulation in KK-Ay Mice with genetic type 2 diabetes. Lipids Health Dis. 2011 Jul 21;10:120.
2. Frigolet ME, et al. The Role of the Novel Lipokine Palmitoleic Acid in Health and Disease. Adv Nutr. 2017 Jan 17;8(1):173S-181S.
3. de Souza CO, et al. Palmitoleic Acid Improves Metabolic Functions in Fatty Liver by PPAR?-Dependent AMPK Activation. J Cell Physiol. 2016 Dec 7.